Activity sensor for pacemaker control
AssigneeCordis Corporation
InventorFrank J. Callaghan
Life of this patent
Estimating the term…
Loading patent…
AssigneeCordis Corporation
InventorFrank J. Callaghan
Estimating the term…
A cardiac pacer is provided which incorporates a sensor responsive to the physical activity of the pacer-wearing patient. The output of the physical activity sensor is utilized by control circuitry of a physiological sensor to enable the physiological sensor to monitor a selected physiological parameter only if the physical activity of the pacer-wearing patient exceeds a selected threshold. In this manner, the electrical energy requirements of the pacer are lessened.
A cardiac pacing system which comprises:
A cardiac pacing system which comprises:
A cardiac pacing system which comprises:
A cardiac pacing system which comprises:
A physiological sensitive cardiac pacing process which comprises the steps of:
A physiological sensitive cardiac pacing process which comprises the steps of:
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
Controlled by a physiological parameter, e.g. heart potential: controlled by two or more physical parameters
Electrotherapy
Term ended 29 Aug 2006 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
The present invention concerns a novel cardiac pacing system, and more particularly, a cardiac pacing system which is responsive to physiological requirements of the body.
Presently, activity-type cardiac pulse generators, namely, cardiac pacers, fall into three major categories.
The first category comprises those cardiac pacers whose output is generally controlled by the patient's or wearer's own cardiac rate. A base or minimum rate is programmed by the physician. When the patient's cardiac rate (either atrial or ventricular or both) decreases below this minimum programmed rate, the output of the cardiac pacer is suppressed. This is not a "true" activity pacer because only the cardiac electrical events dictate the rates or the escape interval of the implanted cardiac pacer. The "escape interval" is the time, usually in milliseconds, between successive output pulses of the cardiac pulse generator. An increase in the escape interval results in a decrease in rate. Conversely, a decrease in escape interval is an increase in rate.
FIG. 1 is an elevational view of a cardiac pacing system constructed in accordance with the principles of the present invention;
FIG. 2 is an elevational view, partially broken for clarity, of the cardiac pacer of FIG. 1 showing the activity sensor positioned within the pacer;
FIG. 3 is a cross-sectional view thereof, taken along the line 3--3 of FIG. 2;
As stated above, in some prior art cardiac pacing systems, the output of an activity sensor directly controls the escape interval of an implanted cardiac pacer. In prior art types of cardiac pacing systems which incorporate a physiological sensor, battery power is necessary to maintain the sensor in the active state. This power constitutes an additional drain on the batteries thereby reducing the useful life of the implantable cardiac pacer.
In the present invention, referring to FIGS. 1-3 and 5, a cardiac pacing system 10 is provided comprising an implantable cardiac pacer 12 having connected thereto a pervenous lead 14. Lead 14 has an electrode 16 at its distal end for stimulating ventricular cardiac muscle and for sensing ventricular electrical activity. The electrical activity is transmitted through an insulated helical wire 17 (FIG. 5) located within the body 18 of the pervenous lead 14. The helical wire 17 forms a connection with the pacer circuitry 19 (FIG. 5) through the neck 20 of the pacer 12.
On the pervenous lead 14, exposed to the blood, is a sensor 22 which measures the partial pressure of oxygen (pO.sub.2). The current needed to maintain the sensor 22 "on" and also to carry the information signal with respect to the pO.sub.2 status is carried by two insulated wires 24, 25 (FIG. 5) which are contained within the pervenous lead body 18.